References
- Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. doi:10.1002/ijc.2921025220842
- Center MM, Jemal A, Lortet-Tieulent J, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61(6):1079–1092. doi:10.1016/j.eururo.2012.02.05422424666
- Ilic D, Neuberger MM, Djulbegovic M, Dahm P. Screening for prostate cancer. Cochrane Database Syst Rev. 2013;(1):Cd004720.23440794
- Donovan JL, Hamdy FC, Lane JA, et al. Patient-Reported Outcomes after monitoring, surgery, or radiotherapy for prostate cancer. N Engl J Med. 2016;375(15):1425–1437. doi:10.1056/NEJMoa160622127626365
- Hamdy FC, Donovan JL, Lane JA, et al. 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med. 2016;375(15):1415–1424. doi:10.1056/NEJMoa160622027626136
- Chen RC, Clark JA, Talcott JA. Individualizing quality-of-life outcomes reporting: how localized prostate cancer treatments affect patients with different levels of baseline urinary, bowel, and sexual function. J Clin Oncol. 2009;27(24):3916–3922. doi:10.1200/JCO.2008.18.648619620493
- Stiggelbout AM, Van der Weijden T, De Wit MP, et al. Shared decision making: really putting patients at the centre of healthcare. BMJ. 2012;344:e256. doi:10.1136/bmj.e25622286508
- Elwyn G, Frosch D, Thomson R, et al. Shared decision making: a model for clinical practice. J Gen Intern Med. 2012;27(10):1361–1367. doi:10.1007/s11606-012-2077-622618581
- Charles C, Gafni A, Whelan T. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med. 1999;49(5):651–661.10452420
- Mottet N, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2017;71(4):618–629. doi:10.1016/j.eururo.2016.08.00327568654
- Parker C, Gillessen S, Heidenreich A, Horwich A. Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26 Suppl 5:v69–v77. doi:10.1093/annonc/mdv22226205393
- Graham J, Kirkbride P, Cann K, Hasler E, Prettyjohns M. Prostate cancer: summary of updated NICE guidance. BMJ. 2014;348:f7524. doi:10.1136/bmj.f752424401467
- Xiong T, Turner RM, Wei Y, Neal DE, Lyratzopoulos G, Higgins JP. Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis. BMJ Open. 2014;4(5):e004285. doi:10.1136/bmjopen-2013-004285
- Martinez-Gonzalez NA, Plate A, Senn O, Markun S, Rosemann T, Neuner-Jehle S. Shared decision-making for prostate cancer screening and treatment: a systematic review of randomised controlled trials. Swiss Med Wkly. 2018;148:w14584. doi:10.4414/smw.2018.1457529473938
- Egger M, Smith GD, Altman DG. Principles of and procedures for systematic reviews In: Egger M, Smith GD, Altman DG, editors. Systematic Reviews in Health Care. 2nd ed. London (UK): BMJ Publishing Group; 2008:23–42.
- Higgins JPT Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration; 2009 [updated September 2011]. Available from: www.cochrane-handbook.org. Accessed March, 2018.
- Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100. doi:10.1371/journal.pmed.100010019621070
- Charles C, Gafni A, Whelan T. Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango). Soc Sci Med. 1997;44(5):681–692.9032835
- Shay LA, Lafata JE. Where is the evidence? A systematic review of shared decision making and patient outcomes. Med Decis Making. 2015;35(1):114–131. doi:10.1177/0272989X1455163825351843
- Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi:10.1136/bmj.d592822008217
- Review Manager (RevMan) [Computer Program]. Version 5.3.5. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014 Available from: http://community.cochrane.org/
- Davison BJ, Goldenberg SL, Wiens KP, Gleave ME. Comparing a generic and individualized information decision support intervention for men newly diagnosed with localized prostate cancer. Cancer Nurs. 2007;30(5):E7–E15. doi:10.1097/01.NCC.0000290819.22195.d617876177
- Hack TF, Pickles T, Bultz BD, Ruether JD, Degner LF. Impact of providing audiotapes of primary treatment consultations to men with prostate cancer: a multi-site, randomized, controlled trial. Psychooncology. 2007;16(6):543–552. doi:10.1002/pon.109416991107
- Mishel MH, Germino BB, Lin L, et al. Managing uncertainty about treatment decision making in early stage prostate cancer: a randomized clinical trial. Patient Educ Couns. 2009;77(3):349–359. doi:10.1016/j.pec.2009.09.00919819096
- Davison BJ, Degner LF. Empowerment of men newly diagnosed with prostate cancer. Cancer Nurs. 1997;20(3):187–196.9190093
- Grossman DC, Curry SJ, Owens DK, et al. Screening for prostate cancer: US preventive services task force recommendation statement. JAMA. 2018;319(18):1901–1913. doi:10.1001/jama.2018.371029801017
- Carlsson S, Leapman M, Carroll P, et al. Who and when should we screen for prostate cancer? Interviews with key opinion leaders. BMC Med. 2015;13:288. doi:10.1186/s12916-015-0526-x26612204
- Bell N, Connor Gorber S, Shane A, et al. Recommendations on screening for prostate cancer with the prostate-specific antigen test. Can Med Assoc J. 2014;186(16):1225–1234. doi:10.1503/cmaj.14070325349003
- Coulter A, Parsons S, Askham J. Health Systems and Policy Analysis. Policy Brief: Where are the Patients in Decision-Making about Their Own Care? Copenhagen (Denmark): European Observatory on Health Systems and Policies, WHO Regional Office for Europe; 2008.
- Carter HB, Albertsen PC, Barry MJ, et al. Early detection of prostate cancer: AUA guideline. J Urol. 2013;190(2):419–426. doi:10.1016/j.juro.2013.04.11923659877
- de Angst IB, Kil PJM, Bangma CH, Takkenberg JJM. Should we involve patients more actively? Perspectives of the multidisciplinary team on shared decision-making for older patients with metastatic castration-resistant prostate cancer. J Geriatr Oncol. 2019. doi:10.1016/j.jgo.2018.12.003
- Nazim SM, Fawzy M, Bach C, Ather MH. Multi-disciplinary and shared decision-making approach in the management of organ-confined prostate cancer. Arab J Urol. 2018;16(4):367–377. doi:10.1016/j.aju.2018.06.00830534434
- Elwyn G, Frosch D, Rollnick S. Dual equipoise shared decision making: definitions for decision and behaviour support interventions. Implement Sci. 2009;4(1):75. doi:10.1186/1748-5908-4-7519922647